NeuroMetrix, Inc.
NURO
$4.41
$0.08591.99%
| Weiss Ratings | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.80 | |||
| Price History | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.21% | |||
| 30-Day Total Return | 0.82% | |||
| 60-Day Total Return | 9.80% | |||
| 90-Day Total Return | 3.30% | |||
| Year to Date Total Return | 12.24% | |||
| 1-Year Total Return | 14.57% | |||
| 2-Year Total Return | -62.24% | |||
| 3-Year Total Return | -86.75% | |||
| 5-Year Total Return | -70.83% | |||
| 52-Week High % Change | -6.75% | |||
| 52-Week Low % Change | 65.82% | |||
| Price | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.73 | |||
| 52-Week Low Price | $2.66 | |||
| 52-Week Low Price (Date) | Aug 13, 2024 | |||
| 52-Week High Price (Date) | Nov 01, 2024 | |||
| Valuation | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.09M | |||
| Enterprise Value | -3.90M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.03 | |||
| Earnings Per Share Growth | -35.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.97 | |||
| Price/Book (Q) | 0.63 | |||
| Enterprise Value/Revenue (TTM) | -1.29 | |||
| Price | $4.41 | |||
| Enterprise Value/EBITDA (TTM) | 0.48 | |||
| Enterprise Value/EBIT | 0.48 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.04M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 890 9989 | |||
| Address | 4B Gill Street Woburn, MA 01801 | |||
| Website | www.neurometrix.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -270.42% | |||
| Profit Margin | -257.38% | |||
| Management Effectiveness | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -27.90% | |||
| Return on Equity | -- | |||
| Income Statement | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.03M | |||
| Total Revenue (TTM) | 3.03M | |||
| Revenue Per Share | $1.49 | |||
| Gross Profit (TTM) | 1.71M | |||
| EBITDA (TTM) | -8.11M | |||
| EBIT (TTM) | -8.20M | |||
| Net Income (TTM) | -7.81M | |||
| Net Income Avl. to Common (TTM) | -7.81M | |||
| Total Revenue Growth (Q YOY) | -55.77% | |||
| Earnings Growth (Q YOY) | -7.93% | |||
| EPS Diluted (TTM) | -4.03 | |||
| EPS Diluted Growth (Q YOY) | 39.01% | |||
| Balance Sheet | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 13.10M | |||
| Cash Per Share (Q) | $6.41 | |||
| Total Current Assets (Q) | 15.01M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | 14.31M | |||
| Current Ratio (Q) | 14.828 | |||
| Book Value Per Share (Q) | $6.98 | |||
| Total Assets (Q) | 15.32M | |||
| Total Current Liabilities (Q) | 1.01M | |||
| Total Debt (Q) | 107.40K | |||
| Total Liabilities (Q) | 1.01M | |||
| Total Common Equity (Q) | 14.31M | |||
| Cash Flow | NURO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 5.35M | |||
| Cash from Financing (TTM) | 1.48M | |||
| Net Change in Cash (TTM) | -304.20K | |||
| Levered Free Cash Flow (TTM) | -3.79M | |||
| Cash from Operations (TTM) | -7.13M | |||
